Study details
Enrolling now
iLIVE Trial
OHSU Knight Cancer Institute
NCT IDNCT06011499ClinicalTrials.gov data as of Apr 2026
Target enrollment
250
Study length
about 3.8 years
Ages
18+
Locations
2 sites in AL, OR
What this study is about
This trial is testing a weight loss plus resistance training intervention (iLIVE) to reduce obesity and improve frailty in men with prostate cancer who are receiving androgen deprivation therapy. The goal of this online program is to help these men maintain their health and quality of life.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Education Intervention
- 2.Internet-Based Diet Intervention
- 3.Internet-Based Exercise Intervention
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Change in quality of life